Hepatobiliary complications of immune checkpoint inhibitors in cancer
Immune checkpoint inhibitors (ICIs) have dramatically changed the landscape of cancer therapy. Over the last decade, both their primary focus in trials and clinical application have exponentially risen, with repeated demonstrations of their efficacy in improving survival in various cancer types. The...
Saved in:
Main Authors: | Donna Zhuang (Author), David Zhang (Author), Stephen Riordan (Author) |
---|---|
Format: | Book |
Published: |
Open Exploration Publishing Inc.,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiovascular complications of immune checkpoint inhibitors
by: A. A. Kulievа, et al.
Published: (2020) -
How to Monitor Cardiac Complications of Immune Checkpoint Inhibitor Therapy
by: Paolo Spallarossa, et al.
Published: (2020) -
Resistance to immune checkpoint inhibitors in gastric cancer
by: Kai Liu, et al.
Published: (2023) -
An overview of immune checkpoint inhibitors in breast cancer
by: Federica Miglietta, et al.
Published: (2020) -
HEPATOBILIARY COMPLICATIONS OF PARENTERAL NUTRITION IN CHILDREN
by: R. F. Tepaev, et al.
Published: (2013)